(Q35191614)

7 August 2017

title

Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation (English)

1 reference

7 August 2017

1 reference

1 reference

1 reference

1

Marta Boffito

1 reference

7 August 2017

Akil Jackson

2

1 reference

7 August 2017

Alieu Amara

3

1 reference

7 August 2017

David Back

4

1 reference

7 August 2017

Saye Khoo

5

1 reference

7 August 2017

Chris Higgs

6

1 reference

7 August 2017

Natalia Seymour

7

1 reference

7 August 2017

Brian Gazzard

8

1 reference

7 August 2017

Graeme Moyle

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

27 June 2011

1 reference

7 August 2017

number of pages

6

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

7 August 2017

volume

55

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

4218-4223

1 reference

Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Atazanavir for the treatment of human immunodeficiency virus infection

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Principles and practice of HIV-protease inhibitor pharmacoenhancement

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Once daily dosing improves adherence to antiretroviral therapy.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165362

https://api.fatcat.wiki/v0/release/2bup2ubnrfc77ftjqqbsnjfv2e

27 September 2018

Identifiers

1 reference

30 July 2022

release_2bup2ubnrfc77ftjqqbsnjfv2e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2bup2ubnrfc77ftjqqbsnjfv2e

30 July 2022

https://api.fatcat.wiki/v0/release/2bup2ubnrfc77ftjqqbsnjfv2e

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/2bup2ubnrfc77ftjqqbsnjfv2e

1 reference

30 July 2022